Home > Name List By n > N-[3-[5-(2-aminopyrimidin-4-yl)-2-tert-butyl-1, 3-thiazol-4-yl]-2-fluorophenyl]-2,6-difluorobenzenesulfonamide

CAS No 1195765-45-7 , N-[3-[5-(2-aminopyrimidin-4-yl)-2-tert-butyl-1,
3-thiazol-4-yl]-2-fluorophenyl]-2,6-difluorobenzenesulfonamide

  • Name: N-[3-[5-(2-aminopyrimidin-4-yl)-2-tert-butyl-1,
    3-thiazol-4-yl]-2-fluorophenyl]-2,6-difluorobenzenesulfonamide
  • Synonyms: Dabrafenib; GSK2118436A; Tafinlar; 1195765-45-7; GSK-2118436; Dabrafenib (USAN); Dabrafenib [USAN:INN]; UNII-QGP4HA4G1B; SureCN806377
  • CAS Registry Number:
  • Density: 1.443
  • Molecular Weight: 519.56241
  • InchiKey: BFSMGDJOXZAERB-UHFFFAOYSA-N
  • InChI: InChI=1S/C23H20F3N5O2S2/c1-23(2,
    3)21-30-18(19(34-21)16-10-11-28-22(27)29-16)12-6-4-9-15(17(12)26)31-35
    (32,33)20-13(24)7-5-8-14(20)25/h4-11,31H,1-3H3,(H2,27,28,29)
  • Molecular Formula: C23H20F3N5O2S2
  • Molecular Structure:CAS No:1195765-45-7 N-[3-[5-(2-aminopyrimidin-4-yl)-2-tert-butyl-1,<br />3-thiazol-4-yl]-2-fluorophenyl]-2,6-difluorobenzenesulfonamide

Related products

Select to

1195765-45-7 Dabrafenib

  • Dabrafenib Dabrafenib (GSK2118436) is a mutant BRAFV600 specific inhibitor with IC50 of 0.8 nM, with 4- and 6-fold less potency against B-Raf(wt) and c-Raf, respectively. IC50 value: 0.8 nM (BRAFV600) [1] Target: BRAFV600 in vitro: Dabrafenib is sele...
  • United States MedChemexpress LLC [Manufacturer]
  • Tel: 609-228-6898
  • Fax: --
  • Address: 18 Wilkinson Way, Princeton, NJ 08540, USA Princeton,New JerseyUnited States
Contact Supplier

Select to

1/1